Anti-seizure medications (ASMs) provide vital therapy to millions of individuals with epilepsy of different types and origins. Second-generation ASMs such as levetiracetam and lamotrigine can provide safe and effective therapy while avoiding or minimizing negative side effects and adverse events associated with first-generation medications.
A white paper reviews the key role laboratory evaluation plays in patient care.
